NCT00428012View on ClinicalTrials.gov

Quality of Life Therapy for Adults With ESRD Awaiting Renal Transplantation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

April 30, 2011

Conditions
End-stage Renal Disease
Interventions
BEHAVIORAL

Quality of Life Therapy

8 weekly individual counseling sessions

BEHAVIORAL

Supportive Therapy

8 weekly individual counseling sessions

Trial Locations (1)

02215

The Transplant Center, Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER

NCT00428012 - Quality of Life Therapy for Adults With ESRD Awaiting Renal Transplantation | Biotech Hunter | Biotech Hunter